Program Criteria

Eligibility Criteria

  • Applications will be accepted from 1 NGO that is a patient organization and 1 NGO that is a healthcare institution. Applications from individuals will not be allowed.
  • The grant amount requested in funding cannot exceed 25% of an organization’s overall funding. Applicants will be accepted from any region or country unless prohibited by national laws
  • Programs must be nonpromotional and should not include mention of any particular medicine but may refer to class of treatment
  • Each organization may submit only one entry
  • Submissions must be received no later than 12:00 AM Eastern Standard Time on June 16, 2023
  • Submissions are restricted to the application form and may not include additional attachments

Apply for the Precision Oncology Patient Innovation Awards

View more details on how to apply

Exclusion Criteria

  • Applications that do not serve or plan to address specific needs related to the cancer community will not be reviewed
  • Applicants may not submit a grant application relating to a program for which funding is already being provided by Bayer
  • Employees of Bayer, VOZ, and other vendors or members of the immediate family of any such persons are not eligible
  • Review panel members and their organizations are not eligible
  • The review panel reserves the right to exclude submissions that could be perceived as being too closely aligned with either themselves or Bayer and its interests
  • Payment will not be made to individuals; for healthcare professionals, payment can be made to an institution. Individuals, or other companies interested in applying will need to partner with a non-profit or other organization
  • Funding provided to the selected applicant will not cover indirect costs

Apply for the Precision Oncology Patient Innovation Awards

View more details on how to apply
    • The review panel will select two programs to receive a grant of $50,000 USD each or the equivalent in the applicants' local currency
    • The review panel’s decision will be final, and no appeals will be permitted
    • Successful applicants will receive a grant request letter and be asked to countersign a copy of Bayer’s Terms and Conditions before receiving the funds. (These relate to the provision of unrestricted grants for scientific or educational use.)
    • Proposed initiatives should be initiated within 6 months of receiving funds
    • Grant recipients should provide a full report 1 year after receiving funds and/or at the end of the program, and describe what the project achieved. If special dispensation is required, this should be agreed upon at the start
    • Successful applicant names/institutions will be published on this website and publicly disclosed information will be shared with the cancer community